Помповая инсулинотерапия: новые технологии в современной клинической практике


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Основная цель лечения сахарного диабета - это достижение оптимального гликемического контроля на долгосрочной основе. Поэтому внедрение в клиническую практику эффективных и безопасных способов “управления" гликемией является крайне важной задачей. Одним из наиболее перспективных направлений современной диабетологии с этой точки зрения считается помповая инсулинотерапия. Настоящий обзор посвящен оценке клинической эффективности дозаторов инсулина, рассмотрению особенностей их устройства и функционирования.

Полный текст

Доступ закрыт

Об авторах

А. С Аметов

РМАПО

д.м.н., профессор

Б. И Валитов

РМАПО

Н. А Черникова

РМАПО

к.м.н, доцент

М. Б Анциферов

Эндокринологический диспансер ДЗ, Москва

д.м.н., профессор

Список литературы

  1. Сунцов Ю.И., Болотская Л.Л., Маслова О.В., Казаков И.В. Эпидемиология сахарного диабета и прогноз его распространенности в Российской Федерации // Сахарный диабет 2011. № 1. С. 15-8.
  2. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. The Diabetes Control and Complications Trial. N Engl J Med 1993;329:977-86.
  3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulpho nylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet 1998;352:837-53.
  4. Болотова Н.В., Компанией, О.В., Филина Н.Ю., Поляков В.К. Опыт использования помповой инсулинотерапии у детей и подростков с сахарным диабетом 1 типа // Сахарный диабет 2010. № 4. С. 93-96.
  5. Емельянов А.О., Кураева Т.Л., Лаптев Д.Н., Петеркова В.А. Проспективное наблюдение эффективности и безопасности помповой инсулинотерапии у детей и подростков // Сахарный диабет 2010. № 3. С. 143-46.
  6. Bergenstal R.M., Tamborlane W.V., Ahmann A., et al., for the STAR 3 Study Group. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes. N Engl J Med 2010; 363:311-20.
  7. De Vries J., Snoek F., Kostense P., Masurel N.A. Randomized Trial of Continuous Subcutaneous Insulin Infusion and Intensive Injection Therapy in Type 1 Diabetes for Patients with LongStanding Poor Glycemic Control. Diabetes Care 2002;25:2074-80.
  8. Hendrychova T., Matoulkova P., Vlcek J., Smahelova A. An overview of so far published analyses comparating the effectiveness of the treatment with insulin pump and multiple daily injections in type 1 diabetes mellitus. Vnitr Lek 2012;58:89-93.
  9. Hirsch B., Bode B., Garg S., et al. Insulin Aspart CSII/MDI Comparison Study Group. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005;28:533-38.
  10. Home P.D., Capaldo B., Burrin J.M., et al. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulindependent diabetic subjects: improved control with CSII. Diabetes Care 1982;5:466-71.
  11. Howard C.Z. The OmniPod Insulin Management System: the latest innovation in insulin pump therapy. Diabetes Ther 2010;1:10-24.
  12. Karagianni P., Sampanis C., Katsoulis C., et al. Continuous subcutaneous insulin infusion versus multiple daily injections. HIPPOKRATIA 2009;13:93-6.
  13. Matejko B., Cyganek K., Katra B., et al. Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients. Rev Diabet Stud 2011;8:254-58.
  14. Nathan D.M., Lou P., Avruch J. Intensive, conventional and insulin pump therapy in adult type
  15. diabetes. A crossover study. Ann Intern Med 1982;97:31-6.
  16. Retnakaran R., DeVries J.H., Hanaire-Broutin H., et al. Continuous subcutaneous insulin infusion versus multiple daily injections. Modeling predicted benefits in relationship to baseline A1c. Diabetes Care 2005;28:1835-36.
  17. Retnakaran R., Hochman J., DeVries J.H., et al. Continuous subcutaneous insulin infusion versus multiple daily injections. The impact of baseline A1c. Diabetes Care 2004;27:2590-96.
  18. Alemzadeh R., Ellis J.N., Holzum M.K., et al. Beneficial Effects of Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Insulin Regimen Using Insulin Glargine in Type 1 Diabetes. J Pediatr 2004;114:91-5.
  19. Bruttomesso D., Pianta A., Crazzolara D., et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med 2002; 19:628-34.
  20. Jeitler K., Horvath K., Berghold A., et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941-51.
  21. Schiaffini R., Ciampalini P., Spera S., et al. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev 2005;21:347-52.
  22. Doyle E., Weinzimer S., Steffen A., et al. Randomized, Prospective Trail Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion with Multiple Daily Injections Using Insulin Glargine. Diabetes Care 2004; 27:1554-58.
  23. Hanas R., Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatric Diabetes 2006;7:25-31.
  24. Scrimgeour L., Cobry E., McFann K., et al. Improved Glycemic Control After Long-Term Insulin Pump Use in Pediatric Patients with Type 1 Diabetes. Diabetes Technol Ther 2007;9:421 -28.
  25. Sulli N., Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4-year follow-up. Diabet Med 2006;23:900-06.
  26. Weinzimer S.A., Ahern J.H., Doyle E.A., et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-605.
  27. Pickup J.C., Kidd J., Burmiston S., Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabete Metab Res Rev 2006;22:232-37.
  28. Hammond P. NICE guidance on insulin pump therapy: time for a re-appraisal? Pract Diabet Int 2005;22:115-16.
  29. Barnard K.D., Lloyd C.E., Skinner T.C. Systematic literature review: quality of life associated with insulin pump use in type 1 diabetes. Diabet Med 2007;24:607-17.
  30. Hoogma R., Hammon P., Gomist R., et al., on behalf of the 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5 nations trial. Diabet Med 2006;23:141-47.
  31. Linkeschova R., Raoul M., Bott U., et al. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002; 19:746-51.
  32. Nicoucci A., Maione A., Franciosis M., et al. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008;25:213-20.
  33. Rubin R.R., Peyrot M. STAR 3 Study Group. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetes Technol Ther 2012;14:143-51.
  34. Boland E.A., Grey M., Oesterle A., et al. Continuous subcutaneous insulin infusion: a new way to achieve strict metabolic control, decrease severe hypoglycemia and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22:1779-84.
  35. Deiss D., Hartmann R., Hoeffe J., Kordonouri O. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diabetes 2004;5:117-21.
  36. Norris S.L., Engelgau M.M., Narayan K.M.V. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001;24:561-87.
  37. Ooi H.L., Wu L.L. Insulin pump therapy in children and adolescents with Type 1 Diabetes: improvements in glycemic control and patients' satisfaction - Hospital UKM experience. Med J Malaysia 2011;66:308-12.
  38. Ramachandani N., Ten S., Anhalt H., et al. Insulin Pump Therapy from the Time of Diagnosis of Type 1 Diabetes. Diabetes Technol Ther 2006; 8:663-70.
  39. Raskin P., Bode B.W., Marks J.B., et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 2003;26:2598-603.
  40. Wainstein J., Metzger M., Boaz M., et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 2005;22:1037-46.
  41. Monami M., Lamanna C., Marchionni N., Mannucci E. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. Exp Clin Endocrinol Diabetes 2009;117:220-22.
  42. Herman W.H., Ilg L.L., Johnson S.L., et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28:1568-73.
  43. Pickap J.C., Renard E. Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes. Diabetes Care 2008;31(2):140-45.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2012

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах